Why Should Payers Attend?
Join us to evaluate cost effectiveness and potential for broad adoption of innovative treatments (payers).
- Understand key long term safety and efficacy profiles justifying treatment costs for chronic conditions
- Compare various GLP-1 drug combinations, their efficacy, safety, and patient outcomes.
